12:30:00 PM PDT - Friday, April 10th, 2020

China suspends Bristol-Myers' cancer drug sales over findings at U.S. plant  

By Editor - Wed Mar 25, 9:48 am

  • Comments Off on China suspends Bristol-Myers' cancer drug sales over findings at U.S. plant

The suspension by the China National Medical Products Administration was announced by partner Beigene Ltd and confirmed by Bristol-Myers on Wednesday. Beigene and Bristol-Myers were working to restore supply as soon as possible, said China-based Beigene, which signed an agreement with Bristol-Myers’ Celgene unit in 2017 to market and distribute Abraxane. “This decision only applies to the China market and does not impact our ability to supply Abraxane outside of China,” Bristol-Myers said in an emailed statement.

See original here:

China suspends Bristol-Myers' cancer drug sales over findings at U.S. plant

  • Comments Off on China suspends Bristol-Myers' cancer drug sales over findings at U.S. plant

Leave a Reply

Comments are closed on this post.